newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics to Report Third Quarter Financial Results on November 15

TEL AVIV, Israel and NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical stage company developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune or inflammatory indications, tod